Topoisomerase II−Drug Interaction Domains: Identification of Substituents on Etoposide That Interact with the Enzyme
- 20 June 2007
- journal article
- research article
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 46 (28), 8217-8225
- https://doi.org/10.1021/bi700272u
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- DNA Topoisomerases: Structure, Function, and MechanismAnnual Review of Biochemistry, 2001
- Anticancer drug design based on plant-derived natural productsJournal of Biomedical Science, 1999
- Topoisomerase II and the Response to Antileukemic TherapyLeukemia & Lymphoma, 1998
- Spontaneous DNA Lesions Poison Human Topoisomerase IIα and Stimulate Cleavage Proximal to Leukemic 11q23 Chromosomal BreakpointsBiochemistry, 1997
- DNA topoisomerase II mutations and resistance to anti‐tumor drugsBioEssays, 1995
- A Yeast Type II Topoisomerase Selected for Resistance to QuinolonesPublished by Elsevier ,1995
- Effects of antineoplastic drugs on the post-strand-passage DNA cleavage/religation equilibrium of topoisomerase IIBiochemistry, 1991
- Structure-activity relations, cytotoxicity and topoisomerase II dependent cleavage induced by pendulum ring analogues of etoposideEuropean Journal of Cancer and Clinical Oncology, 1990
- Purification and characterization of an altered topoisomerase II from a drug-resistant Chinese hamster ovary cell lineBiochemistry, 1989
- Comparison of cytotoxicity and DNA breakage activity of congeners of podophyllotoxin including VP16-213 and VM26: a quantitative structure-activity relationshipBiochemistry, 1984